These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1103622)

  • 1. Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study.
    Seeff LB; Zimmerman HJ; Wright EC; Schiff ER; Kiernan T; Leevy CM; Tamburro CH; Ishak KG
    Am J Med Sci; 1975; 270(1):41-7. PubMed ID: 1103622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of liver disease in former drug users.
    Cherubin CE; Schaefer RA; Rosenthal WS; McGinn T; Forte F; Purcell R; Walmsley P
    Am J Med Sci; 1976; 272(3):244-53. PubMed ID: 1015510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis: clinical aspects.
    Redeker AG
    Am J Med Sci; 1975; 270(1):9-16. PubMed ID: 171956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B serologic studies in narcotic users with chronic liver disease.
    Novick DM; Gelb AM; Stenger RJ; Yancovitz SR; Adelsberg B; Chateau F; Kreek MJ
    Am J Gastroenterol; 1981 Feb; 75(2):111-5. PubMed ID: 7234835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis B surface antigen and antibody in healthy subjects and patients with liver disease.
    Zuberi SJ; Lodi TZ; Samad F
    J Pak Med Assoc; 1978 Jan; 28(1):2-3. PubMed ID: 96284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of asymptomatic hepatitis B surface antigen carriers.
    de Franchis R; Meucci G; Vecchi M; Tatarella M; Colombo M; Del Ninno E; Rumi MG; Donato MF; Ronchi G
    Ann Intern Med; 1993 Feb; 118(3):191-4. PubMed ID: 8417636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viral hepatitis in drug-addicts: anatomo-clinical correlations].
    Camarri E; Corsini P; Marchettini G; Almi P; de' Santi MM; del Vecchio MT; Leoncini L; Cintorino M; Luzi P; Tosi P
    Clin Ter; 1984 Aug; 110(4):311-26. PubMed ID: 6237867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatopathy of the drug addict. Morphological data and incidence of serological markers of hepatitis B virus in 65 patients].
    Gottardi E; Di Marco G
    Minerva Med; 1984 Nov; 75(45-46):2733-9. PubMed ID: 6521944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver tests, HB-Ag and HB-Ab in asymptomatic drug addicts.
    Mangla JC; Kim YM; Brown MR; Schwob D; Hanson SE
    Am J Gastroenterol; 1976 Feb; 65(2):121-6. PubMed ID: 1274938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent HB antigenemia: associated clinical manifestations and hepatic lesions.
    Klatskin G
    Am J Med Sci; 1975; 270(1):33-40. PubMed ID: 171951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [B virus, delta agent and human immunodeficiency virus infections in drug addicts].
    Buffet C; Gagnepain A; Hagege H; Balian P; Espinoza P
    Presse Med; 1988 Sep; 17(30):1533-7. PubMed ID: 2971941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Hippie" hepatitis: an epidemiologic investigation conducted within a population of "street-people".
    Saslow AR; Hammon WM; Rycheck RR; Streiff E; Lewis J
    Am J Epidemiol; 1975 Mar; 101(3):211-9. PubMed ID: 803778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of HBe antigen and anti-HBe antibody in viral hepatitis B (author's transl)].
    Chossegros P; Trepo C; Brette R; Chevallier P; Vitviski L; Sepetjan M
    Nouv Presse Med; 1981 May; 10(24):1993-6. PubMed ID: 7255135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease in drug addicts: clinical course-toxicological and clinical pharmacological aspects.
    May B; Helmstaedt D
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):50-6. PubMed ID: 170228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow up of chronic hepatitis B virus infection in intravenous drug abusers and homosexual men.
    Moestrup T; Hansson BG; Widell A; Nordenfelt E; Hägerstrand I
    Br Med J (Clin Res Ed); 1986 Mar; 292(6524):854-7. PubMed ID: 3083909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients.
    Rao KV; Kasiske BL; Anderson WR
    Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
    Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
    J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of delta virus infection in Thai intravenous drug abusers.
    Louisirirotchanakul S; Wasi C; Uneklabh C; Phutiprawan T; Suwanagool S; Chainuvati T; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):191-5. PubMed ID: 3227398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.